Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: November 8, 2019
Reporting Period: Single event date (November 8, 2019)
Business Context: The registrant is an emerging growth company incorporated in Delaware. This filing serves to disclose upcoming investor and analyst presentations and incorporates an investor presentation as an exhibit.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing regarding disclosure of non-public information and does not contain a financial statement or earnings release.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document solely announces the intent of executive officers to use specific presentation materials during upcoming investor meetings.
Guidance, Outlook, and Risks
- Management Commentary: Executive officers plan to utilize the material in Exhibit 99.1 (Investor Presentation dated November 2019) for upcoming presentations to investors and analysts.
- Regulatory Status: The information provided under Item 7.01 is furnished pursuant to Regulation FD and is explicitly not deemed "filed" for purposes of Section 18 of the Exchange Act, nor is it incorporated by reference into other filings unless expressly stated.
- Exhibits: Exhibit 99.1 contains the referenced investor presentation.
Investor Verification Checklist
- Review Exhibit 99.1 (Investor Presentation dated November 2019) for specific financial data and strategic outlook, as the 8-K text itself contains no numerical metrics.
- Verify the date and content of the upcoming investor presentations mentioned by management.
- Confirm the company's status as an emerging growth company and its election regarding extended transition periods for accounting standards.